Jones Trading Upgrades CervoMed to Buy, Announces $15 Price Target

Benzinga · 1d ago
Jones Trading analyst Soumit Roy upgrades CervoMed (NASDAQ:CRVO) from Hold to Buy and announces $15 price target.